June is Alzheimer’s Awareness Month
Alzheimer’s Disease is a degenerative condition affecting the brain. The most common symptoms observed in affected individuals are:
- memory loss
- changes in ability to create and follow plans, including financial records, cooking/recipes, and work-related projects
- difficulty accomplishing familiar tasks like household chores, driving to a regular destination, or remembering how to operate common household electronics
- being confused about what time it is or where they are located
- balance problems and trouble with spatial recognition, which may lead to increased incidence of falling, injuries, or appear as ‘clumsiness’
- problems finding spoken and written words, such as not remembering the right name for objects or actions, or losing track when in the middle of a thought
- losing or misplacing items frequently
- decreased ability to make informed decisions or loss of ability to judge outcomes or consequences
- social withdrawal
- changes in personality, or even just mood changes that are out of character
If you or a loved one are at risk or want to know your possible risks for Alzheimer’s Disease, there are a number of options to test for this condition, especially when its only in the early stages, and may even be asymptomatic in some people.
The Vibrant Neural Zoomer Plus
While researchers and medical experts still do not have definitive answers regarding the true underlying or root causes of Alzheimer’s Disease and other neurological degenerative conditions, there are a number of theories and findings that all seem to point to an increased toxic burden on the brain, in one form or another (perhaps cumulatively from many, even).
Everything from common infections like viruses to exposure to environmental heavy metals or other toxicants from industrial manufacturing, to even electromagnetic frequencies has been (and continues to be) studied.
Vibrant developed the Neural Zoomer Plus, a landmark antibody test with 48 antibodies to various structures, cells, neurotransmitters, neuropeptides, cellular receptors, and more as a broad and comprehensive screening tool for all manner of brain- and neurological-health-related assessment.
Included in the Neural Zoomer Plus’s antigen list are 11 which have been specifically connected to Alzheimer’s Disease and dementia in clinical studies:
- Anti-Endothelin A receptor
- Anti-Alpha synuclein
- Anti-Amyloid beta (1-42)
- Anti-a1 and B2 adrenergic receptors
- Anti-RAGE peptide
- Anti-Amyloid Beta 25-35
For more information about the Vibrant Neural Zoomer Plus, click here to view the test utility, sample report, and more.
Thanks to advances in integrative approaches to treating neurological degenerative conditions, there is hope that these conditions do not need to be a prison for individuals, and their families, living with them.
The first step to creating individualized treatment approaches that work, however, is accurate testing to determine where the inflammation exists, in order to determine where it may have come from.